Pharmacogenomics: New paradigms for targeted therapy based on individual response to drugs

Urol Oncol. 2014 Jan;32(1):1-4. doi: 10.1016/j.urolonc.2013.08.027.
No abstract available

Keywords: Biomarker; Bladder cancer; Genomic profiling; Pharmacogenomics; Prostate cancer; Renal cancer; Targeted therapy.

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Biomarkers, Tumor / analysis
  • Humans
  • Kidney Neoplasms / drug therapy
  • Kidney Neoplasms / genetics*
  • Male
  • Pharmacogenetics / methods*
  • Pharmacogenetics / trends*
  • Prostatic Neoplasms / drug therapy
  • Prostatic Neoplasms / genetics*
  • Urinary Bladder Neoplasms / drug therapy
  • Urinary Bladder Neoplasms / genetics*

Substances

  • Antineoplastic Agents
  • Biomarkers, Tumor